Primary Care Clinics in Shoreview, MN Accepting Medicare
9 Primary Care Clinics found. Showing 1 - 9
 Lifelight Counseling Services, Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 1030 County Road E W, Shoreview, MN 55126 Phone: 763-340-2310 |
Kids Abilities, Inc Clinic/Center Medicare: Medicare Enrolled Practice Location: 490 Highway 96 W, Suite 300, Shoreview, MN 55126 Phone: 651-451-3016 |
Allina Health Shoreview Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 4194 Lexington Ave N, Shoreview, MN 55126 Phone: 651-483-5461 Fax: 651-483-2215 |
Minnhealth - Shoreview Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 Highway 96 W, Shoreview, MN 55126 Phone: 651-483-8283 Fax: 651-483-8299 |
Preferred Chiropractic Associates Inc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3570 Lexington Ave N, #208, Shoreview, MN 55126 Phone: 651-481-1488 Fax: 651-481-8051 |
Minnesota Vitality And Anti-aging Center Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 520 Highway 96 W Ste 200, Shoreview, MN 55126 Phone: 651-374-4014 Fax: 651-374-4019 |
Entira Family Clinics-shoreview Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 Highway 96 W, Shoreview, MN 55126 Phone: 651-788-4444 Fax: 651-483-8299 |
Vaagenes Chiropractic, Llc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 470 Highway 96 W, Suite 160, Shoreview, MN 55126 Phone: 651-415-0446 Fax: 651-415-0447 |
Schenk Chiropractic, Pa Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3508 North Rice St, Shoreview, MN 55126 Phone: 651-271-3624 |
News Archive
BioLife Solutions granted U.S. patent covering new method of preserving cells, tissues or organs
BioLife Solutions announced today that it was granted a U.S. patent that covers the methods and compositions for the preservation of cells, tissues or organs in the vitreous state.
Social injustice is killing people on a grand scale reports WHO's Commission
A child born in a Glasgow, Scotland suburb can expect a life 28 years shorter than another living only 13 kilometres away. A girl in Lesotho is likely to live 42 years less than another in Japan. In Sweden, the risk of a woman dying during pregnancy and childbirth is 1 in 17 400; in Afghanistan, the odds are 1 in 8. Biology does not explain any of this. Instead, the differences between - and within - countries result from the social environment where people are born, live, grow, work and age.
Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells.
ACT TIL therapy effective in treating metastatic melanoma
Researchers at Moffitt Cancer Center have carried out a clinical trial in which patients with metastatic melanoma were given chemotherapy and an immunotherapy of adoptive cell transfer (ACT) with tumor infiltrating lymphocytes (TIL).
Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome
Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.
› Verified 5 days ago